BMEA - Biomea Fusion, Inc.
1.7
0.030 1.765%
Share volume: 1,131,765
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.67
0.03
0.02%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-02-2024 | 07-31-2023 | 10-30-2023 | 10-29-2024 | 05-02-2024 | 07-31-2024 | 10-29-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 30.031 M | 27.657 M | 31.119 M | 37.328 M | 41.059 M | 38.898 M | 34.039 M | |
| Selling general and admin | 5.636 M | 5.719 M | 5.772 M | 6.462 M | 7.283 M | 7.073 M | 6.795 M | |
| Research and development | 24.395 M | 21.938 M | 25.347 M | 30.866 M | 33.776 M | 31.825 M | 27.244 M | |
| Total expenses | 30.031 M | 27.657 M | 31.119 M | 37.328 M | 41.059 M | 38.898 M | 34.039 M | |
| -7.91% | 12.52% | 19.95% | 10.00% | -5.26% | -12.49% | |||
| Operating income | -30.031 M | -27.657 M | -31.119 M | -37.328 M | -41.059 M | -38.898 M | -34.039 M | |
| Ebit | -30.031 M | -27.657 M | -31.119 M | -37.328 M | -41.059 M | -38.898 M | -34.039 M | |
| Pretax income | -29.051 M | -24.891 M | -28.429 M | -34.884 M | -39.061 M | -37.276 M | -32.787 M | |
| -14.32% | 14.21% | 22.71% | 11.97% | -4.57% | -12.04% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -29.051 M | -24.891 M | -28.429 M | -34.884 M | -39.061 M | -37.276 M | -32.787 M | |
| 14.32% | -14.21% | -22.71% | -11.97% | 4.57% | 12.04% |
